Clinical Electron Beams Flashcards
What are electrons?
A directly ionising particle that interacts with intra-atomic coulomb fields.
Briefly describe the cause of bremsstrahlung.
Inelastic collisions with nuclei.
Breifly describe the cause of ionisation and excitation of electrons.
Inelastic collisions with atomic electrons.
Briefly describe the cause of directional change and negligible energy loss of electrons.
Elastic scattering & soft collisions with atomic electrons.
What are the 4 basic electron interactions?
Excitation, Ionisation, Bremsstrahlung and Characteristic radiation.
What makes electrons clinically attractive?
They deposit dose superficially.
What is the equation for electron fluence?
Φ = dN / da
What is the equation for electron energy fluence?
Ψ = dN / da * E(bar) where E(bar) is the average incident electron energy
What is the electron path length?
Total distance travelled before coming to rest.
What is the electron range?
The sum of the individual path lengths in the original direction of travel.
Range < path length
Define range straggling.
Electrons with same initial energy travel to different depths due to different interaction histories. Higher energies exhibit more range straggling.
What is electron scatter dependent upon?
Atomic number of medium
Energy of the electron beam
What is the cause of the electron PDD shape?
Excitation and ionisation in the build up region:
Scattering results in increasing energy deposited in shallow layers of tissue = ‘Build up effect’.
Decrease after peak: Excitation and ionisation results in deposition of energy at shallow depths, electron beam loses energy, electrons reach end of range and PDD decreases rapidly.
Bremsstrahlung tail.
Increase energy – shallower gradient & surface dose increases due to more ion pairs created.
Lower energy = deviate path more = scatter = sharper drop off
Relative change from surface to depth = not as high for higher energy as less deflection.
Describe the features of electron isodose shapes.
- Applicator size is greater than width of 80% isodose
- Surface dose is dependent on beam energy, distance from applicator, use of cutouts
- High isodose levels are constricted laterally at depth
- Increased scatter at low electron energies results in low dose isodoses ‘bulging’ outwards
What is the advantage of using SXT over electrons?
SXT gives tight penumbras, electrons do not. This is better for OARs in tight proximity.
What literature is relevant to clinical use of electron beams?
ICRU 71: Prescribing, Recording and Reporting Electron Beam Therapy
How many reporting levels are specified in ICRU 71?
3
What is the criteria used to choose a reference point?
- Dose at point clinically relevant
- Point easy to define, unambiguous
- Dose accurately determined
- Point in region where there is no steep gradient
(generally chosen to be at Dmax but away from inhomogeneity & steep gradients).
What is the criteria used to choose a reference point in a single field?
- At centre of PTV
- On central axis of radiation beam
- Preferably at level of peak dose
Also report dose to any OAR too
What is required to give dose data?
A CT scan.
Why is the 90% isodose usually chosen for prescribing instead of the 95% in electron therapy?
It is difficulat to encompass the PTV with the 95%, thus the 90% is used for prescribing but higher is accepted within the target.
Describe the 3 reporting levels for electron beam therapy.
Level 1:
- Dose at ICRU reference point
- Peak absorbed dose on CAX of beam
- Max dose to PTV
- Min dose to PTV
- Usually based on measurements on beam axis.
- ICRU reference point often the point of peak dose on CAX
Level 2 & 3:
- Same as level 1
- Dose to OARs (determined from DVH or dose distribution, which required TPS and accurate diagnostic information)
Define the therapeutic interval.
Distance between the selected isodose suitable for the purposes of the treatment.
Often 80% or 90% isodose
Increasing energy = increases range & interval. But lower energies are desired due to their steeper drop off.
What factors should be considered when doing clinical planning for electron beam therapy?
- Therapeutic interval
- Dose at ICRU Reference Point
- Dmax and Dmin
- Surface dose
- Critical structures
- Inhomogeneities
What happens to PDDs with increasing electron energy?
- Surface dose increases
- Depth of dose max increases
- d50, d80 & Rp increase in depth
- Gradient of fall-off decreases
- X-ray contamination level increases
What is the effect of inhomogeneities on PDDs and dose distributions in electron beam therapy?
Inhomogeneities in medium impact on the scattering of the electrons in the medium. The change in scattering and hence the dose deposited depends on density and atomic composition of inhomogeneity.
Thus we need to consider dose in heterogeneity, beyond and adjacent of inhomogeneity.
What is the effect of bone on electron dose distributions?
- increased attenuation
- greater scattering per linear depth in medium
- increase dose in bone
- decreased dose beyond bone
- increased dose adjacent bone
Density/Scatter does not change dose deposition for electrons as much as say SXT (due to dependence on Z).
What effect does high Z and high density have on electron dose distributions?
More electrons are scattered away from high density, high Z materials to low density, lower Z material.
This results in a increased electron fluence and therefore dose scatter lobes in the lower density or low Z material .